Efficacy of rituximab in acquired factor XIII inhibitor after arterial rFVIIa-induced thrombosis

Haemophilia

Volumn 19, Issue 2, 2013, Pages

  Ngo Sack, F ^a   Galinat, H ^b   Egreteau, P Y ^b   Mollard, L M ^a   Fortin, H ^b   Berthou, C ^a   Abgrall, J F ^b   Pan Petesch, B ^b  

^a CHU MORVAN   (France)

^b UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 13 CONCENTRATE; BLOOD CLOTTING FACTOR 7A; ENOXAPARIN; FRESH FROZEN PLASMA; HEMOGLOBIN; HEPARIN; RITUXIMAB;

ACQUIRED FACTOR XIII INHIBITORS; AGED; ANEMIA; ARTERY THROMBOSIS; ATHEROSCLEROTIC PLAQUE; BLEEDING DISORDER; CASE REPORT; CONTINUOUS INFUSION; DRUG EFFICACY; FEMALE; HEMATOMA; HUMAN; LETTER; MALLEOLUS FRACTURE; PRIORITY JOURNAL; RARE DISEASE; SUPERFICIAL FEMORAL ARTERY; THROMBOSIS; THROMBOSIS PREVENTION; TREATMENT DURATION;

AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; BLOOD COAGULATION FACTOR INHIBITORS; COAGULANTS; FACTOR VIIA; FACTOR XIII DEFICIENCY; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; RECOMBINANT PROTEINS; THROMBOSIS; TREATMENT OUTCOME;

EID: 84874116444     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.12069     Document Type: Letter

References (10)

1. Ichinose A, Souri M on behalf of the Japanese collaborative research group on «Acquired haemorrha-philia due to factor XIII deficiency». As many as 12 cases with haemorrhagic acquired factor XIII deficiency due to its inhibitors were recently found in Japan. Thromb Hemost 2011; 105: 926-7.
2. Ichinose A. Hemorrhagic acquired factor XIII (13) deficiency and acquired hemorrhaphilia 13 revisited. Semin Thromb Hemost 2011; 37: 382-8.
3. Luo YY, Zhang GS. Acquired factor XIII inhibitor: clinical features, treatment, fibrin structure and epitope determination. Haemophilia 2011; 17: 393-8.
4. Hayashi T, Kadohira Y, Morishita E, Asakura H, Souri M, Ichinose A. A case of acquired F XIII deficiency with severe bleeding symptoms. Haemophilia 2012; 18: 618-20.
5. Nijenhuis AVM, van Bergeijk L, Huijgens PC, Zweegman S. Acquired factor XIII deficiency due to an inhibitor: case report and review of the literature. Haematologica 2004; 89: 46-8.
6. Miesbach W, Boehm M, Scharrer I. Rituximab in the treatment of factor XIII inhibitor possibly caused by Ciprofloxacin. Thromb Haemost 2005; 93: 1001-3.
7. Gregory TF, Cooper B. Case report of an acquired factor XIII inhibitor: diagnosis and management. Proc (Bayl Univ Med Cent) 2006; 19: 221-3.
8. Franchini M, Frattini F, Crestani S, Bonfanti C. Acquired F XIII inhibitors: a systematic review. J Throm Thrombol 2012. doi:10.1007/s11239-012-0818-3. (Epub ahead of print).
9. Ajzner E, Schlammadinger A, Kerenyi A et al. Severe bleeding complications caused by an autoantibody against the B subunit of plasma factor XIII: a novel form of acquired factor XIII deficiency. Blood 2009; 113: 723-5.
10. Collins P, Baudo F, Knoebl P et al. on behalf of the EACH2 registry collaborators. Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). Blood 2012; 120: 47-55.